92 related articles for article (PubMed ID: 8531348)
1. [Production and role of B cell growth factor (BCGF) in Sjögren's syndrome].
Goto Y; Ito M
Nihon Rinsho; 1995 Oct; 53(10):2418-21. PubMed ID: 8531348
[TBL] [Abstract][Full Text] [Related]
2. Increased production of B cell growth factor (BCGF) in Sjögren's syndrome.
Goto Y; Itoh M; Ogawa N; Goto Y; Ohashi H; Ohno R
J Autoimmun; 1996 Aug; 9(4):545-50. PubMed ID: 8864831
[TBL] [Abstract][Full Text] [Related]
3. An analysis of polyclonal B cell activation in Sjögren's syndrome. Characterization of B cell lines spontaneously established from the peripheral blood.
Miyasaka N; Yamaoka K; Sato K; Kubota T; Okuda M; Nishioka K; Ohya Y; Yamamoto K
Scand J Rheumatol Suppl; 1986; 61():123-6. PubMed ID: 3495872
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
5. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.
Skopouli FN; Fox PC; Galanopoulou V; Atkinson JC; Jaffe ES; Moutsopoulos HM
J Rheumatol; 1991 Feb; 18(2):210-4. PubMed ID: 1827160
[TBL] [Abstract][Full Text] [Related]
6. Biochemical deficiency of pyridoxine does not affect interleukin-2 production of lymphocytes from patients with Sjögren's syndrome.
Tovar AR; Gómez E; Bourges H; Ortíz V; Kraus A; Torres N
Eur J Clin Nutr; 2002 Nov; 56(11):1087-93. PubMed ID: 12428174
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
[TBL] [Abstract][Full Text] [Related]
8. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
9. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of activation of B lymphocytes in idiopathic UIP: evaluation of BCGF and BCDF-production from blood T lymphocytes].
Emura M
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Dec; 27(12):1467-74. PubMed ID: 2630767
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.
Yoshizaki K; Nakagawa T; Fukunaga K; Kaieda T; Maruyama S; Kishimoto S; Yamamura Y; Kishimoto T
J Immunol; 1983 Mar; 130(3):1241-6. PubMed ID: 6600479
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
[TBL] [Abstract][Full Text] [Related]
14. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
[TBL] [Abstract][Full Text] [Related]
15. B cell hyperresponsiveness in Sjögren's syndrome.
Yamoaka K; Miyasaka N; Sato K; Okuda M; Nishioka K
Autoimmunity; 1989; 3(4):261-9. PubMed ID: 2491631
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
[TBL] [Abstract][Full Text] [Related]
17. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS
J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603
[TBL] [Abstract][Full Text] [Related]
18. Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndrome.
Morawietz L; Martinez-Gamboa L; Scheffler S; Hausdorf G; Dankof A; Kuckelkorn U; Doerner T; Egerer K; Burmester GR; Faustman DL; Feist E
J Rheumatol; 2009 Dec; 36(12):2694-703. PubMed ID: 19833746
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
[TBL] [Abstract][Full Text] [Related]
20. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
